Plasma noradrenaline (NA) levels were compared between two groups of patients with major depressive disorder (melancholic/psychotic and non-melancholic), patients with general anxiety disorders and healthy controls. The melancholic/psychotic depressed group had the highest plasma NA levels. This only reached statistical significance with respect to the control group. Within the depressed group, there was no association between plasma NA levels and age, weight loss, ratings of depression, anxiety or plasma cortisol levels. Variance of plasma NA was greatest in the melancholic/psychotic depressed group. A review of previous studies shows an association between raised plasma NA, depressive illness and alterations in NA variance. This association may be limited to melancholic/psychotic depressed patients. The above findings support a dysregulated noradrenergic system in depressive illness.
Ableson J.L., Glitz D., Cameron O.G., Lee M.A., Branzo M., Curtis G.C. (1991) Blunted growth hormone response to clonidine in patients with generalised anxiety disorder. Archs Gen Psychiat48: 157-162
2.
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn (revised). American Psychiatric Association, Washington, DC
3.
Anderson I.M., Parry-Billings M., Newsholme E.A., Poartmans J.R., Cowen PJ (1990) Decreased plasma tryptophan concentrations in major depression: relationship to melancholia and weight loss. J Affect Disord20: 185-191
4.
Armitage P., Berry G. (1987) Statistical methods in medical research. Blackwell Scientific Publications, Oxford, pp.112-115
5.
Barnes R.F., Veith R.C., Barson S., Verhey J., Raskind M.A., Halter J.B. (1983) High levels of plasma catecholamines in dexamethasone resistant depressed patients. Am J Psychiat140:1623-1625
6.
Blum I., Nissiel L., David A., Graff E., Harsat A., Weissglass L., Gabboy U., Sulkes J., Yerushalmy Y., Vered Y. (1992) Plasma neurotransmitter profile during different phases of the ovulatory cycle. J Clin Endocrinol Metab75: 924-929
7.
Brown M.J., Jenner D.A., Allison D.J., Dollery C.T. (1981) Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique: limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci61: 585-590
8.
Cameron O.G., Smith C.B., Lee M.A., Hollingsworth P.G., Hill E.M., Curtis G.C. (1990) Adrenergic status in anxiety disorders: platelet alpha-2-adrenergic receptor binding, blood pressure, pulse and plasma catecholamines in panic and generalised anxiety disorder patients and normal subjects. Biol Psychiat28: 3-20.
9.
Checkley S.A., Glass I.B., Thompson L., Corn T., Robinson P. (1981) The GH response to clonidine in endogenous as compared with reactive depression. Psychol Med14: 773-777
10.
Christensen N.J. (1974) Plasma norepinephrine and epinephrine in untreated diabetes, during fasting and after insulin administration. Diabetes23:1-8
11.
Danish UniversityAntidepressant Group (1990 ) Paroxetine: a selective serotonin uptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affect Disord18: 289-299
12.
DeVilliers A.S., Russell VA, Carsters ME, Aalbers C., Gagiano CA, Charlton DO, Taljaard J.F. (1987) Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary major depressive disorder. Psychiat Res21: 127-139
13.
Dinan T.G., Yatham L.N., O'Keane V., Barry S. (1991) Blunting of noradrenergic stimulated growth hormone release in mania. Am J Psychiat148: 936-938
14.
Duggan C.F., Lee A.S., Murray R.M. (1991) Do different subtypes of hospitalised depressives have different outcomes? Archs Gen Psychiat48: 308-312
15.
Dutka D.P., Olvatto I., Ward S., Nihoyannopoulos P., Al-Subaibi M., Oakley C.M., Impallomeni M., Cleland J.G. (1995) Plasma neuroendocrine activity in very elderly subjects and patients with and without heart failure. Europ Heart J16:1223-1230
16.
Elsworth J.D., Redmond D.E., Roth R.H. (1982) Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates. Brain Res235: 115-124
17.
Esler M.D., Turbott J., Schwarz R., Leonard P., Babik A., Skews H., Jackman G. (1982) The peripheral kinetics of norepinephrine in depressive illness. Archs Gen Psychiat39: 295-300
18.
Esler M.D., Lambert G.W., Ferrier C., Kaye D.M., Wallin B.G., Kalff V., Kelly M.J., Jennings G.L. (1995a) Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertension17: 409-423
19.
Esler M.D., Turner AG, Kaye DM, Thompson J.M., Kingwell BA, Morris M., Lambert G.W., Jennings G.L., Cox H.S., Seals DR (1995b) Aging effects on human sympathetic neuronal function . Am J Physiol268: R278-R285
20.
Extein I., Tallman J., Smith C.C., Goodwin F.K. (1979) Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiat ResI: 191-197
21.
Frank E., Anderson B., Reynolds III C.F., Ritenour A., Kupfer D G J (1994) Life events and the research diagnostic criteria endogenous subtype. Archs Gen Psychiat51: 519-524
22.
Goldstein D.S., Levinson P., Keiser H.R. (1983) Plasma and urinary catecholamines during the human ovulatory cycle. Am J Obstet Gynecol146: 824-829
23.
Gustafson A.B., Kalkoff R.K. (1982) Influence of sex and obesity on plasma catecholamine response to isometric exercise. J Clin Endocrinol Metab55: 703-707
24.
Hamilton M. (1959) The assessment of anxiety states by rating. Br J Med Psychol32: 50-55
25.
Hamilton M. (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol6: 278-296
26.
Healy D., Paykel E.S., Whitehouse A.M., White W., Ashby M., Brown M., Theodarou A.E., Lawrence K.M., Horton R.W. (1992) Plasma noradrenaline, adrenaline, and DHPG responses to clonidine in control and depressed subjects. Hum Psychopharmac7:167-173
27.
Hjemdahl P. (1987) Physiological aspects of catecholamine sampling . Life Sci41: 841-844
28.
Kopin I.J. (1984) Avenues of investigation for the role of catecholamines in anxiety. Psychopathology17: 3-8
29.
Krstulovic A.M., Dziedzic S.W., Bertoni-Dziedzic L., Dirico D.E. (1981) Plasma catecholamines in hypertension and phaeochromocytoma determined using ion pair reverse phase chromatography with amperometric detection . Investigation of separation mechanism and clinical methodology. J Chromatogr217: 523-537
30.
Lake CR, Pickar D., Zeigler MG, Lipper S., Slater S., Murphy DL (1982) High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiat139:1315-1318
31.
Lambert G.W., Ferrier C., Kaye D.M., Jennings G.L., Kalff V., Kelly M.J., Cox H.S., Turner AG, Esler M.D. (1995) Central nervous system norepinephrine turnover in essential hypertension. Ann N Y Acad Sci12: 679-694
32.
Landsberg L., Young J.B. (1978) Fasting, feeding and regulation of the sympathetic nervous system. New Engl J Med298:1295-1301
33.
Lewis A.J. (1938) States of depression: their clinical and aetiological differentiation. BMJii: 875-878
34.
Lista A.L. (1989) Differential rates of urinary noradrenaline excretion in affective disorders: utility of a short time sampling procedure. Psychiat Res30: 253-258
35.
Louis WJ, Doyle A.E., Anavekar S.N. (1975) Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin Sci Mol Med48: 239S-242S
36.
Magliozzi J.R., Gietzen D., Maddock R.J., Haack D., Doran A.R., Goodman T., Weiler PG (1989) Lymphocyte beta-adrenoceptor density in patients with unipolar depression and normal controls. Biol Psychiat26:15-25
37.
Mann J.J., Mahler J.C., Wilner PJ, Halper J.P., Brown R.P., Johnson K.S., Kocsis J.H., Chen J.S. (1990) Normalisation of blunted lymphocyte beta-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy . Archs Gen Psychiat47: 461-464
38.
Mann J.J., Malone K.M., Diehl D.J., Perel J., Cooper T.B., Mintun M.A. (1996) Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiat153:174-182
39.
Martignoni E., Blandini F., Melzi d'Eril G.V., D'Andrea G., Sances G., Costa A., Nappi G. (1993) The influence of gender in the evaluation of platelet and plasma catecholamines. Life Sci52:1995-2004
40.
Matthew R.J., Ho B.T., Francis D.J., Taylor D.L., Weinman M.L. (1982) Catecholamines and anxiety. Acta Psychiat Scand65:142-147
41.
Matussek N., Aikenheil M., Hippius H., Muller F., Schroder HT, Schultes H., Wasilewski B. (1980) Affects of clonidine on growth hormone release in psychiatric patients and controls. Psychiat Res2: 25-26
42.
Morrow L.A., Linares OA, Hill TJ, Sanfield JA, Supiano M.A., Rosen S.G., Halter J.B. (1987) Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans. J Clin Endocrinol Metab65: 508-511
43.
Munjack DJ, Baltazaar PL, De Quattro V., Sabin P., Palmer R., Zulueta A., Crocker B., Usigli R., Buckwalter G., Leonard M. (1990) Generalised anxiety disorder: some biochemical aspects. Psychiat Res32: 35-43
44.
Murburg M.M., McFall M.E., Lewis N., Veith R.C. (1995) Plasma norepinephrine kinetics in patients with post-traumatic stress disorder. Biol Psychiat38: 819-825
45.
Nelson J.C., Mazure C.M., Jatlow P.I. (1990). Does melancholia predict response in major depression . J Affect Disord18: 157-165
46.
Nicholls D.O., O'Connor PC, Harrow D W G, Leahey W.J., Shanks R.G. (1984) Differential blockace of alpha-adrenoceptors by indoramin. Br J Clin Pharmac17: 719-728
47.
Odink J., Van der Ploeg H.M., Van den Berg J., Van Kempen G M J, Bruinse H.W., Lauworse E.S. (1990) Circadian and circatrigintan rhythms of biogenic amines in premenstrual syndrome. Psychosom Med52: 346-356
48.
Pandey G.N., Janicak P.G., Jovaid J.I., Davis J.M. (1989) Increased H3-clonidine binding in the platelets of patients with depressive and schizophrenic disorders. Psychiat Res28: 73-78
49.
Paykel E.S., Cooper Z., Ramana R., Hayhurst H. (1996) Life events social support and marital relationships in the outcome of severe depressions. Psychol Med26:121-133
50.
Reiner P.B. (1986) Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats. Brain Res378: 86-96
51.
Roose S.P., Glassman A.H., Attia E. (1994) Comparitive efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiat151:1735-1739
52.
Roy A., Pickar D., Linnoila M., Potter WZ (1985) Plasma norepinephrine levels in affective disorders . Archs Gen Psychiat42: 1181-1185
53.
Roy A., Jimerson D.C., Pickar D. (1986) Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Am J Psychiat143: 846-851.
54.
Roy A., Guthrie S., Pickar D., Linnoila M. (1987) Plasma norepinephrine response to cold challenge in depressed patients and normal controls. Psychiat Res21: 161-168
55.
Roy A., Pickar D., De Jong J., Karoum F., Linnoila M. (1988) Norepinephrine and its metabolites in cerebrospinal fluid, plasma and urine. Archs Gen Psychiat45: 849-857
56.
Rudorfer M.V., Ross R.J., Linnoila M., Sherer M.A., Potter W.Z. (1985) Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Archs Gen Psychiat42: 1186-1192
57.
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiat122: 509-522
58.
Segal D.S., Kuczenski R., Mandell A.J. (1974) Theoretical implications of drug induced adaptive regulation for a biogenic amine hypothesis of affective disorders. Biol Psychiat9:147-159
59.
Sevy S., Papadimitriou G.N., Surmont D.W., Goldman S., Mendlewicz J. (1989) Noradrenergic function in generalised anxiety disorder, major depressive disorder and healthy subjects. Biol Psychiat25: 141-152
60.
Siever LJ, Davis KL (1985) Overview: Toward a dysregulation hypothesis of depression. Am J Psychiat142: 1017-1029
61.
Siever L.J., Uhde T.W., Jimerson D.C., Lake C.R., Kopin I.J., Murphy D.L. (1986) Indices of noradrenergic output in depression. Psychiat Res19: 59-73
62.
Starkman M.N., Cameron O.G., Nesse R.M., Zebrik T. (1990) Peripheral catecholamine levels and the symptoms of anxiety with and without phaeochromocytoma. Psychosom Med652:129-142
63.
Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh A., Costillo S., Peskind E.R., Pascualy M., Halter J.B. (1994) Sympathetic nervous system activity in major depression . Archs Gen Psychiat51: 411-422
64.
Wyatt R.J., Portnoy B., Kupfer D.J., Synder F., Engelman K. (1971) Resting plasma catecholamine concentrations in patients with depression and anxiety. Archs Gen Psychiat24: 65-70
65.
Zacur H.A., Tyson J.E., Ziegler M.G., Lake C.R. (1978) Plasma dopamine-beta-hydroxylase activity and norepinephrine levels during the human menstrual cycle. Am J Obstet Gynecol130: 148-151
66.
Ziegler M.G., Lake L.R., Wood J.H., Brooks B.R., Ebert M.H. (1977) Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine. J Neurochem28: 677-679
